Higher Levels of Fibrosis in a Cohort of Veterans with Chronic Viral Hepatitis are Associated with Extrahepatic Cancers

2019 Howlander, 1975 Allison, 2015, Incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006–2010, J Hepatol, 63, 822, 10.1016/j.jhep.2015.04.021 Fiorino, 2015, Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: a systematic review, World J Gastroenterol, 21, 12896, 10.3748/wjg.v21.i45.12896 Zignego, 1999, Extrahepatic manifestations of HCV infection: facts and controversies, J Hepatol, 31, 369, 10.1016/S0168-8278(99)80239-6 Tasleem, 2015, Hepatitis C associated B-cell non-hodgkin lymphoma: clinical features and the role of antiviral therapy, J Clin Transl Hepatol, 3, 134 Lingala, 2015, Natural history OF hepatitis C, Gastroenterol Clin N Am, 44, 717, 10.1016/j.gtc.2015.07.003 Bonder, 2014, Utilization of FibroScan in clinical practice, Curr Gastroenterol Rep, 16, 372, 10.1007/s11894-014-0372-6 Liu, 2017, Cancer risk in patients with hepatitis C virus infection: a population-based study in Sweden, Cancer Med, 6, 1135, 10.1002/cam4.988 Mahale, 2017, Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case-control study, Cancer, 123, 1202, 10.1002/cncr.30559 Chang, 2014, Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma, World J Gastroenterol WJG, 20, 5060, 10.3748/wjg.v20.i17.5060 Abe, 2016, Hepatitis B and C virus infection and risk of pancreatic cancer: a population-based cohort study (JPHC study cohort II), Cancer Epidemiol Prev Biomark, 25, 555, 10.1158/1055-9965.EPI-15-1115 Uzun, 2002, The incidence of hepatitis C virus in patients with lung cancer, Turk Respir J, 3, 91 Malaguarnera, 2006, Hepatitis C virus in elderly cancer patients, Eur J Intern Med, 17, 325, 10.1016/j.ejim.2006.02.004 Qadwai, 2017, Hepatitis C virus and nonliver solid cancers: is there an association between HCV and cancers of the pancreas, thyroid, kidney, oral cavity, breast, lung, and gastrointestinal tract?, Gastroenterol Res Pract, 1, 10.1155/2017/8349150 Ioannou, 2019, What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection?, Gastroenterology, 156, 10.1053/j.gastro.2018.10.033 D’ambrosio, 2018, Persistence of hepatocellular carcinoma risk in hepatitis C patients with a response to IFN and cirrhosis regression, Liver Int, 38, 1459, 10.1111/liv.13707 Unalp-Arida, 2017, Liver fibrosis scores predict liver disease mortality in the United States population, Hepatology, 66, 84, 10.1002/hep.29113 De Vincentis, 2019, Association between non-invasive liver fibrosis scores and occurrence of Health adverse outcomes in older people, Dig Liver Dis, 51, 1330, 10.1016/j.dld.2019.01.017 Salomone, 2018, Simple scores of fibrosis and mortality in patients with NAFLD: a systematic review with meta-analysis, J Clin Med, 7, 219 Song, 2019, Associations between hepatitis B virus infection and risk of all cancer types, JAMA Network Open, 2, 10.1001/jamanetworkopen.2019.5718 Lingala, 2015, Natural history of hepatitis C, Gastroenterol Clin N Am, 44, 171, 10.1016/j.gtc.2015.07.003 Huang, 2013, Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden, Br J Canc, 109, 2917, 10.1038/bjc.2013.689 Abe, 2015, Hepatitis B and C virus infection and risk of pancreatic cancer: a population-based cohort study (JPHC study cohort II), Cancer Epidemiol Biomark Prev, 25, 555, 10.1158/1055-9965.EPI-15-1115 Omland, 2010, Hepatitis C virus infection and risk of cancer: a population-based cohort study, Clin Epidemiol, 179, 10.2147/CLEP.S10193 Kawamura, 2008, Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis, J Gastroenterol Hepatol, 23, 1739, 10.1111/j.1440-1746.2008.05436.x Fujita, 2016, Diabetes mellitus and metformin in hepatocellular carcinoma, World J Gastroenterol, 22, 6100, 10.3748/wjg.v22.i27.6100 Shiffman, 2014, Long term changes in liver histology following treatment of chronic hepatitis C virus, Ann Hepatol, 13, 340, 10.1016/S1665-2681(19)30840-3 Mun, 2019, No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk, Eur J Gastroenterol Hepatol, 31, 47, 10.1097/MEG.0000000000001242